A citation-based method for searching scientific literature

Stephen M Ansell, Alexander M Lesokhin, Ivan Borrello, Ahmad Halwani, Emma C Scott, Martin Gutierrez, Stephen J Schuster, Michael M Millenson, Deepika Cattry, Gordon J Freeman, Scott J Rodig, Bjoern Chapuy, Azra H Ligon, Lili Zhu, Joseph F Grosso, Su Young Kim, John M Timmerman, Margaret A Shipp, Philippe Armand. N Engl J Med 2015
Times Cited: 2238



Robert L Ferris, George Blumenschein, Jerome Fayette, Joel Guigay, A Dimitrios Colevas, Lisa Licitra, Kevin Harrington, Stefan Kasper, Everett E Vokes, Caroline Even, Francis Worden, Nabil F Saba, Lara C Iglesias Docampo, Robert Haddad, Tamara Rordorf, Naomi Kiyota, Makoto Tahara, Manish Monga, Mark Lynch, William J Geese, Justin Kopit, James W Shaw, Maura L Gillison. N Engl J Med 2016
Times Cited: 2103




List of shared articles



Times cited

Of immune checkpoint maladies and remedies: The throwing of jabs in the oncogenic ring of PDAC.
Olamide T Olaoba, Funmilayo C Ligali, Zaccheaus O Alabi, Amos O Akinyemi, Kehinde S Ayinde. Biochim Biophys Acta Rev Cancer 2021
0

Potential of circulating immune cells as biomarkers of nivolumab treatment efficacy for advanced hepatocellular carcinoma.
Yi-Ping Hung, Yu-Yun Shao, Jan-Mou Lee, Chiun Hsu, Chih-Hung Hsu, Muh-Hwa Yang, Yee Chao. J Chin Med Assoc 2021
2

PILE: a candidate prognostic score in cancer patients treated with immunotherapy.
D C Guven, H C Yildirim, E Bilgin, O H Aktepe, H Taban, T K Sahin, I Y Cakir, S Akin, O Dizdar, S Aksoy,[...]. Clin Transl Oncol 2021
1

Advanced Nanotechnology for Enhancing Immune Checkpoint Blockade Therapy.
Chiara Cremolini, Emanuela Vitale, Raffaella Rastaldo, Claudia Giachino. Nanomaterials (Basel) 2021
0

Association Between First-Line Immune Checkpoint Inhibition and Survival for Medicare-Insured Patients With Advanced Non-Small Cell Lung Cancer.
Kenneth L Kehl, Scott Greenwald, Nassib G Chamoun, Paul J Manberg, Deborah Schrag. JAMA Netw Open 2021
0


Current strategies for intratumoural immunotherapy - Beyond immune checkpoint inhibition.
Jianda Yuan, Anuradha Khilnani, Joshua Brody, Robert H I Andtbacka, Siwen Hu-Lieskovan, Jason J Luke, Adi Diab, Aurelien Marabelle, Alexandra Snyder, Z Alexander Cao,[...]. Eur J Cancer 2021
0

Nivolumab treatment beyond progressive disease in advanced non-small cell lung cancer.
T Enomoto, A Tamiya, K Matsumoto, Y Adachi, K Azuma, Y Inagaki, S Kouno, Y Taniguchi, N Saijo, K Okishio,[...]. Clin Transl Oncol 2021
0

Immune landscape and therapeutic strategies: new insights into PD-L1 in tumors.
Yuan Wei, Xiao Xiao, Xiang-Ming Lao, Limin Zheng, Dong-Ming Kuang. Cell Mol Life Sci 2021
1

Enhanced Antitumor Immunity via Endocrine Therapy Prevents Mammary Tumor Relapse and Increases Immune Checkpoint Blockade Sensitivity.
Gonzalo R Sequeira, Ana Sahores, Tomás Dalotto-Moreno, Ramiro M Perrotta, Gabriela Pataccini, Silvia I Vanzulli, María L Polo, Derek C Radisky, Carol A Sartorius, Virginia Novaro,[...]. Cancer Res 2021
3

Regulation of PD-L1 expression in the tumor microenvironment.
Ming Yi, Mengke Niu, Linping Xu, Suxia Luo, Kongming Wu. J Hematol Oncol 2021
20

The evolving paradigm of biomarker actionability: Histology-agnosticism as a spectrum, rather than a binary quality.
Paolo Tarantino, Luca Mazzarella, Antonio Marra, Dario Trapani, Giuseppe Curigliano. Cancer Treat Rev 2021
1

Current Immunotherapies for Glioblastoma Multiforme.
Boyuan Huang, Xuesong Li, Yuntao Li, Jin Zhang, Zhitao Zong, Hongbo Zhang. Front Immunol 2021
6

Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
Shaoqing Liu, Qianjie Tang, Jianwen Huang, Meixiao Zhan, Wei Zhao, Xiangyu Yang, Yong Li, Lige Qiu, Fujun Zhang, Ligong Lu,[...]. Aging (Albany NY) 2021
1

Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers.
Rivka R Colen, Christian Rolfo, Murat Ak, Mira Ayoub, Sara Ahmed, Nabil Elshafeey, Priyadarshini Mamindla, Pascal O Zinn, Chaan Ng, Raghu Vikram,[...]. J Immunother Cancer 2021
2

Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy.
Tianqi Wang, Yusuke Suita, Saradha Miriyala, Jordan Dean, Nikos Tapinos, Jie Shen. Pharmaceutics 2021
1

Serum alanine aminotransferase as an early marker of outcomes in patients receiving anti-PD-1 or anti-CTLA-4 antibody.
Takeshi Azuma, Takumi Takeuchi, Yukihide Matayoshi, Shin Namiki, Tetsuya Obara, Kazuhiro Imamura, Mikio Takamori. Sci Rep 2021
0

Treatment-Related Serious Adverse Events of Immune Checkpoint Inhibitors in Clinical Trials: A Systematic Review.
Tao Ouyang, Yanyan Cao, Xuefeng Kan, Lei Chen, Yanqiao Ren, Tao Sun, Liangliang Yan, Bin Xiong, Bin Liang, Chuansheng Zheng. Front Oncol 2021
1

Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy.
Pim P van de Donk, Thijs T Wind, Jahlisa S Hooiveld-Noeken, Elly L van der Veen, Andor W J M Glaudemans, Arjan Diepstra, Mathilde Jalving, Elisabeth G E de Vries, Erik F J de Vries, Geke A P Hospers. Eur J Nucl Med Mol Imaging 2021
1